| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.024 | 0.6 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.066 | 0.6 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.6 |